Pannexin-1 channels as therapeutic targets in post-stroke neuroinflammation

全世界每年约有700万人死于中风，只有不到10%的受害者接受了临床批准的治疗，以减轻中风负担。目前，唯一被批准的中风治疗方法是静脉注射一种酶

Approximately 7 million people world-wide are killed from a stroke annually and less than 10% of victims receive clinically approved therapies to alleviate stroke burden. Currently, the only approved stroke therapy is intravenous administration of an enzy